1,027 results on '"Ratziu, Vlad"'
Search Results
2. A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases
3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
4. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review
5. Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
6. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
7. A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis
8. Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH
9. NIS2+TM as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trials
10. Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
11. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
12. A multisociety Delphi consensus statement on new fatty liver disease nomenclature
13. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
14. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
15. FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial
16. A multisociety Delphi consensus statement on new fatty liver disease nomenclature
17. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
18. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
19. A global research priority agenda to advance public health responses to fatty liver disease
20. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study
21. A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
22. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
23. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
24. Clinical Trial Landscape in NASH
25. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
26. Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
27. Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)
28. Rational combination therapy for NASH: Insights from clinical trials and error
29. NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned
30. Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
31. Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH
32. Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons
33. The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
34. A diagnostic proposal for sarcopenic obesity in adults based on body composition phenotypes
35. The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytes
36. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
37. Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
38. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
39. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
40. Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study.
41. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
42. Advancing the global public health agenda for NAFLD: a consensus statement
43. Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study
44. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
45. Real-World Burden of Nonalcoholic Steatohepatitis
46. European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
47. Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
48. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
49. NASH limits anti-tumour surveillance in immunotherapy-treated HCC
50. MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.